Interaction of plasmid and host quinolone resistance [1]

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 4, 2003, Pages 1037-1039

  Martínez Martínez, Luis ^a   Pascual, Alvaro ^a   García, Isabel ^a   Tran, John ^b,c   Jacoby, George A ^b,c  

^a UNIVERSITY OF SEVILLE   (Spain)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antimicrobial; Escherichia coli; Fluoroquinolone; Klebsiella pneumoniae

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINAFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; LEVOFLOXACIN; MERCURIC CHLORIDE; NALIDIXIC ACID; NORFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; STREPTOMYCIN; SULFONAMIDE; TRIMETHOPRIM; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CHROMOSOME MUTATION; ESCHERICHIA COLI; GENETIC CODE; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; PSEUDOMONAS AERUGINOSA;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 0242432497     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg157     Document Type: Letter

References (12)

1. Martínez-Martínez, L., Pascual, A. & Jacoby, G. A. (1998). Quinolone resistance from a transferable plasmid. Lancet 351, 797-9.
2. Tran, J. H. & Jacoby, G. A. (2002). Mechanism of plasmid-mediated quinolone resistance. Proceedings of the National Academy of Sciences, USA 99, 5638-42.
3. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Wayne, PA, USA.
4. Bachmann, B. J. (1996). Derivations and genotypes of some mutant derivatives of Escherichia coli K-12. In Escherichia coli and Salmonella (Neidhardt, F. C., Ed.), pp. 2460-88. ASM Press, Washington, DC, USA.
5. Hooper, D. C., Wolfson, J. S., Souza, K. S., Tung, C., McHugh, G. L. & Swartz, M. N. (1986). Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy 29, 639-44.
6. Yamagishi, J., Yoshida, H., Yamayoshi, M. & Nakamura, S. (1986). Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Molecular and General Genetics 204, 367-73.
7. Bagel, S., Hüllen, V., Wiedemann, B. & Heisig, P. (1999). Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrobial Agents and Chemotherapy 43, 868-75.
8. Nikaido, H., Rosenberg, E. Y. & Foulds, J. (1983). Porin channels in Escherichia coli: studies with β-lactams in intact cells. Journal of Bacteriology 153, 232-40.
9. George, A. M. & Levy, S. B. (1983). Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. Journal of Bacteriology 155, 531-40.
10. Tomás, J. M., Benedí, V. J., Ciurana, B. & Jofré, J. (1986). Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infection and Immunity 54, 85-9.
11. Benedí, V. J., Ciurana, B. & Tomás, J. M. (1985). Isolation and characterization of Klebsiella pneumoniae unencapsulated strains. Journal of Clinical Microbiology 27, 82-7.
12. Martínez-Martínez L., García, I., Ballesta, S., Benedí, V. J., Hernández-Allés, S. & Pascual, A. (1998). Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains. Antimicrobial Agents and Chemotherapy 42, 1850-2.